Follow Health Care Reform Insider on Twitter
You are here:  Home  >  Emerging Healthcare Models  >  Current Article

Biogen CEO eyes value-based payer deals to boost pressured MS franchise

April 28, 2017 

Facing stepped-up competition for its critical multiple sclerosis business, Biogen CEO Michel Vounatsos contends his company is “ready and well-equipped” to forge ahead. And that includes “value-based and innovative contracting” with payers, the helmsman told analysts on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>